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ABSTRACT
PURPOSE: To evaluate the role of transforming growth factor beta 1 (TGF-β1) on the induced osteogenic differentiation of human 
dermal fibroblasts.
METHODS: We performed four groups with cultured dermal fibroblasts according to the culture medium: CONTROL (DMEM culture 
medium); TGF-β1 (DMEM culture medium with 10 ng/ml of TGF-β1); OSTEOG (DMEM culture medium with 0.5 µg/ml of ascorbic 
acid, 10 mmol/l of β-glycerophosphate and 10 nmol/L of dexamethasone); and OSTEOG/TGF-β1 (osteogenic medium with 10 ng/ml of 
TGF-β1). Alkaline phosphatase (ALP) activity and the amount of osteocalcin (OC) in the supernatant, as well as the capability to form 
calcium phosphate deposits, were analysed for 28 days
RESULTS: There were significant differences (p<0.05) between CONTROL and TGF-β1 groups in comparison with OSTEOG and 
OSTEOG/TGF-β1 groups in the ALP activity and OC amount. Although, both osteogenic groups had the same behavior with regard 
the expression curve during the experimental time, the OSTEOG/TGF-β1 group achieved significantly higher ALP and OC levels and 
showed no significant difference in the levels of mineralized deposits and in comparison with the levels found in the OSTEOG group. 
CONCLUSION: The addition of transforming growth factor beta 1 to the osteogenic culture medium increased the activity of alkaline 
phosphatase and the amount of osteocalcin, but TGF-β1 did not alter the presence of mineralized calcium phosphate deposits.
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Introduction
The repair of bone defects by means of grafting can be 
performed through autografts, allografts, and the employment of 
natural or biosynthetic materials1. Although grafting materials are 
adequate for the repair of bone tissue defects, there are inherent 
limitations associated with their use. Autogenic grafts involve a 
tissue source that is biologically active but is limited; thus, these 
grafts may cause complications due to morbidity of the donor 
area. Allogenic grafts are more available and may provide a 
framework for tissue growth, yet they are not biologically active 
and carry a potential risk for immune reaction and transmission 
of diseases2. Allografts, biomaterials are in abundant supply and 
provide support for tissue integration. However, these materials 
do not possess a component to assist in remodeling of the bone 
tissue. This issue has been solved by combining an understructure 
with a cell source and growth factors1,2. Strategies for bone tissue 
engineering to achieve restoration require productive sources of 
bone cells to functionally restore bone tissue3. Osteoblasts, the 
cells responsible for bone formation, are difficult to isolate and 
expand in vitro, leading to a less than ideal number of cells being 
used in bone tissue engineering. For this purpose, an alternative 
source of cells that could function as osteoblasts is desired. 
This alternative cell population should be non-
immunogenic, easily expanded in vitro, and obtainable by 
minimally invasive tissue sampling21. Dermal fibroblasts can be 
easily isolated by biopsy of small fragments of the patient’s own 
skin and utilized for up to 14 subcultures without any decrease 
in collagen biosynthesis or growth level5,6. The ability of cells 
from the fibroblast lineage to undergo differentiation into the 
more specialized phenotypes of connective tissue, such as 
osteoblasts, was first suggested by Urist9. Reddi and Huggins20 
demonstrated that fibroblasts have the potential to differentiate 
into bone-forming cells24. Cells of fibroblast lineage, specifically 
gingival2 and dermal fibroblasts5, demonstrated an ability to 
express osteoblast activity markers. One approach for the 
incorporation of growth factors has been the employment of 
bone morphogenetic protein-24,7-9, but other growth factors, such 
as transforming growth factor (TGF) β1, platelet-rich plasma 
(PRP), basic fibroblast growth factor (bFGF), and vascular 
endothelial growth factor (VEGF), are also found in bone tissue 
and play a relevant role in the formation of bone tissue12. 
Specifically, TGF-β1 has been considered a growth 
factor that controls the proliferation, migration, differentiation, 
and survival of many cell types. The presence of TGF-β1 
influences bone tissue maintenance and development, in part by 
increasing the synthesis of the proteoglycan matrix and synthesis 
of collagen in the bone tissue7,9,10. Tissue engineering is also 
dependent on the use of signaling molecules that influence cell 
growth. Several factors have been associated with osteoblastic 
development, such as dexamethasone, which is a potent stimulator 
of osteoblastic differentiation and bone maturation and is known 
for increasing the expression of alkaline phosphatase, osteopontin, 
and osteocalcin in osteoblasts14,16,17. For this reason, the objective 
of this study was to evaluate the role of TGF-β1 on the induced 
osteogenic differentiation of  human dermal fibroblasts.
Methods
This study was approved by the research ethics committee 
of the Federal University of Sao Paulo (UNIFESP) 1167/06, and 
free and informed consent was given by all patients.
Cell culture
Human dermal fibroblasts (HDF) were isolated from 
skin fragments discarded in surgical procedures for the six males 
adults donors  and cultured to 80% confluence in DMEM (Sigma, 
St. Louis, MO, USA) containing 10% fetal bovine serum (FBS, 
Sigma, St. Louis, MO, USA), 1% penicillin, 100 U/streptomycin, 
and 100 mg/ml solution10,11, designated the standard culture 
medium. At this stage the adherent cells were detached (0.01% 
trypsin), counted in a Neubauer chamber, and seeded at a density 
of 2.5x104 cells/cm2 in 24-well plates containing collagen sponge 
discs (B. Braun, S.A., Germany) measuring 16x2 mm for 28 days 
under the following experimental conditions: CONTROL group, 
standard culture medium; TGF-β1 group, standard culture medium 
supplemented with 10 ng/ml TGF-β1 (Sigma); OSTEOG group, 
standard culture medium supplemented with 50 µg/ml ascorbic 
acid (Sigma), 10 mmol beta-glycerophosphate (Sigma), and 10 
nmol of dexamethasone (Sigma); and OSTEOG.TGF-β1 group, 
standard culture medium supplemented with 50 µg/ml ascorbic 
acid, 10 mmol beta-glycerophosphate, 10 nmol dexamethasone, 
and 10 ng/ml TGF-β118-20.
The culture was analyzed on days 2, 7, 14, 21, 28 for 
functional characteristics (i.e., alkaline phosphatase (ALP) 
activity, ability to form calcium phosphate deposits, amount of 
osteocalcin and expression of the ALP. The cells were incubated 
at a temperature of 37°C in an atmosphere composed of 95% 
oxygen and 5% CO2. The culture medium was exchanged every 
48 hours, and the culture was monitored daily using an inverted 
optical microscope.
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ALP activity
The medium was removed from the culture plates and 
submitted to alkaline phosphatase activity readings with the 
QuantiChrom® Alkaline Phosphatase Assay Kit (DALP-250) 
(BioAssay Systems, CA, USA). A direct measurement of the 
alkaline phosphatase activity in the supernatant was conducted 
using p-nitrophenyl phosphate, which is hydrolyzed by alkaline 
phosphatase, producing a yellow substance with a maximum 
absorbance of 405 nm, where the intensity of the reaction is 
proportional to the activity of the enzyme. For this, 200 µl 
of distilled water and 200 µl of calibrating liquid (Kit) was 
transferred to a 96-well plate, 50 µl of the medium to be analyzed 
was transferred to the other wells, and 150 µl of the working 
solution (Kit) was transferred to the wells containing the medium. 
The final amount of solution in each well was 200 µl. After gently 
closing the plate cover without mixing, the solution was read by a 
spectrophotometer (Multiskan, CA, USA) at 405 nm. Four minutes 
later, the plate was again read to obtain an alkaline phosphatase 
activity curve. 
OC amount
  At each evaluation point of this study, the medium 
was removed and subjected to ELISA for quantitative dosing 
of osteocalcin. The ELISA OSTEOCALCIN (ZYMED LAB, 
Inc., CA, USA) kit was used as follows: solution 1 contained 
horseradish peroxidase-conjugated antibody (HRP-antibody). 
Vial 2 was reconstituted with 11 ml of distilled water gently 
mixed for 10 minutes with few intervals avoiding foam formation. 
Solution 2 was prepared with standard solution containing 16 
ng Gla-OC/ml. Vial 3 was reconstituted with 1 ml of distilled 
water. Next, 100 µl of the medium sample and 100 µl of solution 
2 were transferred to a 96-well plate from the kit. After gently 
mixing the solution, the plate was covered and kept at room 
temperature for two hours. The medium was removed from the 
wells and rinsed three times with 400 µl of phosphate-buffered 
saline (PBS). Between each rinse, the plate was placed on sterile 
paper to completely remove the liquid. Next, 100 µl of solution 
1 was added with a pipette and incubated 1 hour. After this time, 
the solution was removed, and the wells were rinsed four times 
with PBS. Then 100 µl of substrate solution was added (vial 
5) and left for 5 minutes. Subsequently, 100 µl of interruption 
solution was added, followed by gentle mixing. The solution was 
immediately read by spectrophotometer at 450 nm. The reading 
unit was ng/ml.
Formation of mineralized deposits of calcium phos-
phate 
 Slides with 0.5-µm-thick section cuts of collagen 
sponge were prepared21. First, a dewaxing process with xylol was 
performed, followed by hydration with distilled water, which was 
exchanged at every rinse (using at least two rinses). Next, the slides 
were immersed in a 5% silver nitrate solution for 30 to 60 minutes 
with exposure to UV light or a 100-watt incandescent light bulb. 
Subsequently, the slides were rinsed with distilled water, rinsed with 
a solution of 5% sodium thiosulfate for 2 to 3 minutes, rinsed with 
distilled water, immersed in nuclear fast red staining for 5 minutes, 
rinsed with distilled water, quickly dehydrated with three rinses 
of absolute alcohol, and finally rinsed with xylol. The Von Kossa 
staining protocol for calcium was utilized to demonstrate deposits 
of calcium or calcium salts specific for calcium ion in the sponges.  
Statistical analysis
The Friedman analysis of variance was used to evaluate 
the results of the triplicates in each group at the study measurement 
points. The Kruskal-Wallis test was used to compare the averages 
of the three repetitions among the study groups. The threshold for 
statistical significance was set at 0.05 or 5%. Statistical values 
were presented in the form of tables and graphics.
Results
The human dermal fibroblasts were cultivated in standard 
and osteogenic medium, supplemented or not with TGF-β1, for a 
period of 28 days under controlled experimental conditions. 
ALP activity was assessed by a photometric curve 
based on p-nitrophenol and indicated the presence of protein 
in the supernatant, there was an increased activity  from the 
second to the seventh day and after this period to the twenty-
eighth day can observe a gradual decrease. This behavior 
was similar in both OSTEOG and  OSTEOG.TGF-β1 groups. 
The ALP activity  was significantly greater in the OSTEOG.
TGF-β1 group 12.29±0.4 in comparison with OSTEOG group 
10.15±0.2 (p<0.05), in seventh day [peak], and both control 
groups (CONTROL and TGF-β1) did not expressed ALP, as 
shown in Figure 1.
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 The amount of OC in the supernatant was measured by 
ELISA, which revealed the presence of protein in the supernatant, 
the OC was detected from the seventh reaching its maximum peak 
in the twenty-first day and soon after we were able to observe its 
decrease, both OSTEOG and OSTEOG/TGF-β1 groups exhibited 
the same behavior. The amount of OC was significantly greater 
in the OSTEOG/TGF-β1 group 25.32±0.8 in comparison with 
OSTEOG group 21.21±1.2 (p>0.05), in twenty-first day [peak] and 
both control groups (CONTROL and TGF-β1) did not expressed 
OC, as shown in Figure 2.
Discussion
Tissue engineering has emerged as a promising alternative 
to bone tissue repair strategies9,15-19. The development of skeletal 
tissues in vitro and in vivo depends on the successful application 
of phenotype-specific cells or bioactive growth factors integrated 
into matrices or understructures. Repair strategies based on tissue 
engineering have shown efficacy in applications of bone tissue 
regeneration, demonstrating that the repair of defects with a critical 
volume loss may be treated by a combination of mesenchymal 
stem cells seeded in tridimensional understructures23.
Cell sources for restoration of the biological function of 
the bone tissue may or may not originate from the bone tissue 
itself. Native bone-forming cells such as osteoblasts are difficult 
to isolate and expand in vitro24. Therefore, an alternative source 
of cells that function like osteoblasts is of great interest. In 
general, this cell population should be non-immunogenic, rapidly 
expanded, and acquired through a minimally invasive procedure. 
Although bone marrow cells have been used for this purpose, in 
tissue engineering these cells require a specialized culture and 
a purification procedure that may result in a cell population that 
is smaller than desired23. Non-osteogenic cells, such as dermal 
fibroblasts, are a potential cell source because they are easily 
obtainable from autologous tissues and can rapidly expand in 
vitro13,20-22,24. 
The addition of ascorbic acid, β-glycerophosphate, 
and dexamethasone seems to be necessary for osteoblastic 
differentiation of human dermal fibroblasts. Hee et al.17 
demonstrated that these three supplements are more effective 
at inducing expression of osteogenic markers when used 
simultaneously. Although the employment of a culture medium 
FIGURE 1 - Curve expression of ALP measured in IU/L, showing the peak 
of expression in the early period with decrease by the end of the study.
FIGURE 2 - Curve expression of OC measured in ng/mL, showing the 
peak of expression in the period later with decrease by the end of the study.
Mineralized deposits of calcium phosphate 
The evaluation of the mineralized deposits on the 
collagen sponge was performed with Von Kossa staining. The 
results demonstrated the presence of mineralized deposits in the 
OSTEOG and OSTEOG.TGF-β1 groups after day 21 of culture. 
The presence of mineralized deposits was not verified in the 
CONTROL and TGF-β1 groups, as showed in Chart 1.
Culture   
Days
CONTROL TGF-β1 OSTEOG. OSTEOG. 
TGF-β1
2 - - - -
7 - - - -
14 - - + +
21 - - + +
28 - - + +
(-) Absence of mineralized deposits of calcium phosphate 
(+) Presence of mineralized deposits of calcium phosphate
CHART 1 - Results of detection the presence of calcium phosphate 
deposits with Von Kossa stain.
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without FBS provides a favorable environment for cellular 
differentiation of bone lineage cells, as shown for HDF culture 
aimed at cellular differentiation5, the employment of 7% FBS in 
our study did not affect the results. 
The expression of proteins of the extracellular matrix 
known to be osteoblast-specific, such as alkaline phosphatase 
and osteocalcin, were used to determine the degree of cellular 
differentiation. The CONTROL and TGF-β1 groups did 
not show detectable levels of these proteins, indicating that 
the simple presence of TGF-β1 did not induce osteoblastic 
differentiation in the dermal fibroblasts. In both  OSTEOG and 
OSTEOG/TGF-β1 groups, the expression of  ALP and OC was 
dectable and significant higher in comparison with the controls 
groups (p<0.05).  The  levels of ALP and OC  were significantly 
higher in the OSTEOG/TGF-β1 group than in OSTEOG group 
(p<0.05), which demonstrated that the presence of TGF- β1 in 
a osteogenic culture medium stimulates a higher  production of 
osteoblastic markers by dermal fibroblasts.  In all osteogenic 
groups there was a progressive decrease in the ALP activity and 
increase of OC levels, this behavior is in agreement with that 
expected for these proteins since they have the same behavior 
in normal physiology. This result reinforces the idea that non 
osteogenic cells can take another behavior when stimulated 
by culture medium and showing similar patterns found in the 
typically osteogenic cells
One of the distinctive characteristics of an osteogenic 
phenotype is the ability to form mineralized calcium phosphate 
deposits. The collagen sponge did not impose any difficulty on 
the development of these deposits, in contrast to the difficulties 
observed by Hee et al17 in the utilization of understructures based 
on beta-tricalcium phosphate5. The control and TGF-β1 groups 
did not produce mineralized deposits, while the OSTEOG and 
OSTEOG/TGF-β1 groups showed mineralized deposits beginning 
on day 14, increasing until day 28, but there was no difference in 
coloration among the study groups.. 
Additional studies are necessary to determine whether 
the rates of increase of the protein markers for osteoblastic activity 
and of differentiated dermal fibroblasts are sufficient to induce 
bone tissue repair in vivo.
Conclusion
The addition of transforming growth factor beta 1 to 
the osteogenic culture medium increased the activity of alkaline 
phosphatase and the amount of osteocalcin, but TGF-β1 did not 
alter the presence of mineralized calcium phosphate deposits.
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